{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:53:40Z","timestamp":1791154420564,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["RO1-DA026430"],"award-info":[{"award-number":["RO1-DA026430"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","award":["T32-GM007108"],"award-info":[{"award-number":["T32-GM007108"]}],"id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","award":["F30-DA033747"],"award-info":[{"award-number":["F30-DA033747"]}],"id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-12699"],"award-info":[{"award-number":["MOP-12699"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.nbd.2014.08.009","type":"journal-article","created":{"date-parts":[[2014,8,15]],"date-time":"2014-08-15T17:52:55Z","timestamp":1408125175000},"page":"140-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice"],"prefix":"10.1016","volume":"71","author":[{"given":"Alipi V.","family":"Naydenov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja D.","family":"Sepers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Swinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn A.","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Palmiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nephi","family":"Stella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2014.08.009_bb0005","series-title":"Endocannabinoids: actions at non-CB1\/CB2 cannabinoid receptors","author":"Abood","year":"2012"},{"key":"10.1016\/j.nbd.2014.08.009_bb0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/brain\/awq278","article-title":"Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease","volume":"134","author":"Bl\u00e1zquez","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2014.08.009_bb0015","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.biopsych.2005.03.008","article-title":"Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6\/2 Huntington's disease mice","volume":"57","author":"Centonze","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2014.08.009_bb0025","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","article-title":"Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease","volume":"23","author":"Cepeda","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.009_bb0020","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1523\/JNEUROSCI.2137-12.2013","article-title":"Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models","volume":"33","author":"Cepeda","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.009_bb0030","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1073\/pnas.1400988111","article-title":"A restricted population of CB1 cannabinoid receptors with neuroprotective activity","volume":"111","author":"Chiarlone","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.08.009_bb0035","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.nbd.2011.12.017","article-title":"Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease","volume":"45","author":"Chiodi","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.009_bb0040","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.neuroscience.2009.06.014","article-title":"Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease","volume":"163","author":"Dowie","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.08.009_bb0045","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuroscience.2010.06.056","article-title":"Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington's disease transgenic mice","volume":"170","author":"Dowie","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.08.009_bb0050","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1172\/JCI45646","article-title":"Brain networks in Huntington disease","volume":"121","author":"Eidelberg","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2014.08.009_bb0055","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.08.009_bb0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0306-4522(03)00595-5","article-title":"Delayed onset of Huntington's disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors","volume":"123","author":"Glass","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.08.009_bb0065","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2014.08.009_bb0070","article-title":"Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington's disease and mouse models","volume":"37","author":"Horne","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.009_bb0075","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nm.f.1869","article-title":"Endocannabinoid signaling as a synaptic circuit breaker in neurological disease","volume":"14","author":"Katona","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2014.08.009_bb0080","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","article-title":"Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington's disease transgenic mice","volume":"86","author":"Klapstein","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2014.08.009_bb0085","article-title":"Recurrent network activity drives striatal synaptogenesis","volume":"1\u20138","author":"Kozorovitskiy","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2014.08.009_bb0090","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.neuron.2008.11.005","article-title":"Striatal plasticity and basal ganglia circuit function","volume":"60","author":"Kreitzer","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.08.009_bb0095","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.neuroscience.2007.03.036","article-title":"Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6\/2 mouse model of Huntington's disease","volume":"146","author":"Kung","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.08.009_bb0100","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nbd.2003.08.024","article-title":"Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation","volume":"14","author":"Luthi-Carter","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.009_bb0105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pneurobio.2006.11.006","article-title":"The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases","volume":"81","author":"Maccarrone","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2014.08.009_bb0110","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.nbd.2011.03.006","article-title":"Worsening of Huntington disease phenotype in CB1 receptor knockout mice","volume":"42","author":"Mievis","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.009_bb0115","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.nbd.2007.11.006","article-title":"Gene\u2013environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice","volume":"29","author":"Nithianantharajah","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.009_bb0120","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/dds037","article-title":"Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice","volume":"21","author":"Pouladi","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.08.009_bb0125","first-page":"1547","article-title":"Lack of GPR88 enhances medium spiny neuron activity and alters motor- and cue-dependent behaviors","volume":"15","author":"Quintana","year":"2012","journal-title":"Nat. Publ. Group"},{"key":"10.1016\/j.nbd.2014.08.009_bb0130","first-page":"252","article-title":"Review Pathophysiology of Huntington's Disease: Time-dependent Alterations in Synaptic and Receptor Function","volume":"198","author":"Raymond","year":"2011","journal-title":"NSC"},{"key":"10.1016\/j.nbd.2014.08.009_bb0135","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.0953-816X.2004.03374.x","article-title":"Dendritic spine pathology and deficits in experience dependent dendritic plasticity in R6\/1 Huntington's disease transgenic mice","volume":"19","author":"Spires","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.009_bb0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","article-title":"The Hdh(Q150\/Q150) knock-in mouse model of HD and the R6\/2 exon 1 model develop comparable and widespread molecular phenotypes","volume":"72","author":"Woodman","year":"2007","journal-title":"Brain Res. Bull."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611400240X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611400240X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T01:44:51Z","timestamp":1565747091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999611400240X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":28,"alternative-id":["S096999611400240X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2014.08.009","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2014.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}